Insulin and ischemia stimulate glycolysis by acting on the same targets through different and opposing signaling pathways

Journal of Molecular and Cellular Cardiology

Volumn 34, Issue 9, 2002, Pages 1091-1097

  Hue, Louis ^a   Beauloye, Christophe ^a   Marsin, Anne Sophie ^a   Bertrand, Luc ^a   Horman, Sandrine ^a   Rider, Mark H ^a  

^a International Institute of Cellular and Molecular Pathology   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

6 PHOSPHOFRUCTO 2 KINASE; FRUCTOSE 2,6 BISPHOSPHATE; GLUCOSE TRANSPORTER 4; INSULIN; PROTEIN KINASE B;

CONFERENCE PAPER; ENZYME ACTIVATION; ENZYME INHIBITION; GLYCOLYSIS; HEART MUSCLE ISCHEMIA; HEART MUSCLE METABOLISM; HUMAN; METABOLIC REGULATION; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

EID: 0036751393     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-2828(02)92063-8     Document Type: Conference Paper

References (35)

1. Depre C, Rider MH, Hue L. Mechanisms of control of heart glycolysis. Eur J Biochem 1998; 258: 277-290.
2. Maroko PR, Libby P, Sobel BE, Bloor CM, Sybers HD, Shell WE, Covell JW, Braunwald E. Effect of glucose-insulin-potassium infusion on myocardial infarction following experimental coronary artery occlusion. Circulation 1972; 45: 1160-1175.
3. Diaz R, Paolasso EA, Piegas LS, Tajer CD, Moreno MG, Corvalan R, Isea JE, Romero G on behalf of the ECLA collaborative group. Metabolic modulation of acute myocardial infarction. The ECLA Glucose-Insulin-Potassium Pilot Trial. Circulation 1998: 98: 2227-2234.
4. Vanoverschelde JLJ, Janier MF, Bakke JE, Marshall DR, Bergmann SR. Rate of glycolysis during ischemia determines extent of ischemic injury and functional recovery after reperfusion. Am J Physiol 1994: 267: H1785-H1794.
5. Depre C, Vanoverschelde JL, Taegtmeyer H. Glucose for the heart. Circulation 1999: 99: 578-588.
6. Kashiwaya Y, Sato K, Tsuchiya N, Thomas S, Fell DA, Veech RL, Passonneau JV. Control of glucose utilization in working perfused rat heart. J Biol Chem 1994; 269: 25502-25514.
7. Liang Q, Donthi RV, Kralik PM, Epstein PN. Elevated hexokinase increases cardiac glycolysis in transgenic mice. Cardiovasc Res 2002: 53: 423-430.
8. Hue L, Rider MH. Role of fructose 2,6-bisphosphate in the control of glycolysis in mammalian tissues. Biochem J 1987; 245: 313-324.
9. Van Schaftingen E. Fructose 2,6-bisphosphate. Adv Enzymol Areas Mol Biol 1987; 59: 315-395.
10. Pilkis SJ, Claus TH, Kurland IJ, Lange AJ. 6-Phosphofructo-2-kinase/fructose-2,6-bisphosphatase: a metabolic signaling enzyme. Annu Rev Biochem 1995: 64: 799-835.
11. Rider MH, van Damme J, Vertommen D, Michel A, Vandekerckhove J, Hue L. Evidence for new phosphorylation sites for protein kinase C and cyclic AMP-dependent protein kinase in bovine heart 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase. FEBS Lett 1992; 310: 139-142.
12. Bertrand L, Alessi DR, Deprez J, Deak M, Viaene E, Rider MH, Hue L. Heart 6-phosphofructo-2-kinase activation by insulin results from Ser-466 and Ser-483 phosphorylation and requires 3-phosphoinositide-dependent kinase-1, but not protein kinase B. J Biol Chem 1999; 274: 30927-30933.
13. Deprez J, Vertommen D, Alessi DR, Hue L, Rider MH. Phosphorylation and activation of heart 6-phosphofructo-2-kinase by protein kinase B and other protein kinases of the insulin signaling cascades. J Biol Chem 1997: 272: 17269-17275.
14. Marsin AS, Bertrand L, Rider MH, Deprez J, Beauloye C, Vincent MF, Van den Berghe G, Carling D, Hue L. Phosphorylation and activation of heart PFK-2 by AMPK has a role in the stimulation of glycolysis during ischaemia. Curr Biol 2000: 10: 1247-1255.
15. Cushman SW, Goodyear LJ, Pilch PF, Ralston E, Galbo H, Ploug T, Kristiansen S, Klip A. Molecular Mechanism involved in GLUT 4 translocation in muscle during insulin and contraction stimulation. Adv Exp Med Biol 1998; 441: 63-71.
16. Saltiel AR, Pessin JE. Insulin signaling pathways in time and space. Trends Cell Biol 2002; 12: 65-71.
17. Saltiel AR, Kahn CR. Insulin signaling and the regulation of glucose and lipid metabolism. Nature 2001; 414: 799-806.
18. Alessi DR. Discovery of PDK1, one of the missing links in insulin signal transduction. Colworth Medal Lecture. Biochem Soc Trans 2001: 29: 1-14.
19. Rider MH, Hue L. Activation of heart phosphofructo-kinase-2 by insulin in vivo. FEBS Lett 1984; 176: 484-488.
20. Lefebvre V, Mechin MC, Louckx MP, Rider MH, Hue L. Signaling pathway involved in the activation of heart 6-phosphofructo-2-kinase by insulin. J Biol Chem 1996; 271: 22289-22292.
21. Deprez J, Bertrand L, Alessi DR, Krause U, Hue L, Rider MH. Partial purification and characterization of a wortmannin-sensitive and insulin-stimulated protein kinase that activates heart 6-phosphofructo-2-kinase. Biochem J 2000: 347: 305-312.
22. Hayashi T, Hirshman MF, Kurth EJ, Winder WW, Goodyear LJ. Evidence for 5′AMP-activated protein kinase mediation of the effect of muscle contraction. Diabetes 1998; 47: 1369-1373.
23. Kurth-Kraczek EJ, Hirshman MF, Goodyear LJ, Winder WW. 5′AMP-activated protein kinase activation causes GLUT 4 translocation in skeletal muscle. Diabetes 1999; 48: 1667-1671.
24. Russel RR, Bergeron R, Shulman GI, Young LH. Translocation of myocardial GLUT-4 and increased glucose uptake through activation of AMPK by AICAR. Am J Physiol 1999: 277: H643-H649.
25. Hardie DG, Carling D, Carlson M. The AMP-activated/SNF1 protein kinase subfamily: Metabolic Sensors of the Eukariotic Cell? Annu Rev Biochem 1998; 67: 821-855.
26. Hardie DG and Hawley SA. AMP-activated protein kinase: the energy charge hypothesis revisited. Bioessays 2001: 23: 1112-1119.
27. Kudo N, Barr AJ, Barr RL, Desai S, Lopaschuck GD. High rates of fatty acid oxidation during reperfusion of ischemic hearts are associated with a decrease in malonyl-CoA levels due to an increase in 5′ AMP-activated protein kinase inhibition of acetyl-CoA carboxylase. J Biol Chem 1995; 270: 17513-17520.
28. Kudo N, Gillepsie JG, Kung L, Witters LA, Schulz R, Clanachan AS, Lopaschuck GD. Characterization of 5′ AMP-activated protein kinase activity in the heart and its role in inhibiting acetyl-CoA carboxylase during reperfusion following ischemia. Biochim Biophys Acta 1996; 1301: 67-75.
29. Egert S, Nguyen N, Brosius FC, Schwaiger M. Effects of wortmannin on insulin- and ischemia-induced stimulation of GLUT-4 translocation and FDG uptake in perfused rat hearts. Cardiovasc Res 1997; 35: 283-293.
30. Sun DQ, Nguyen N, Degrado TR, Schwaiger M, Brosius FC. Ischemia induces translocation of the insulin-responsive glucose transporter GLUT-4 to the plasma membrane of cardiac myocytes. Circulation 1994; 89: 793-798.
31. Beauloye C, Bertrand L, Krause U, Marsin AS, Dresselaers T, Vanstapel F, Vanoverschelde JL, Hue L. No-flow ischemia inhibits insulin signaling in heart by decreasing intracellular pH. Circ Res 2001: 88: 513-519.
32. Jonassen AK, Sack MN, Mjos OD, Yellon DM. Myocardial protection by insulin at reperfusion requires early administration and is mediated via Akt and p70s6 kinase cell-survival signaling. Circ Res 2001: 89: 1191-1198.
33. Witters LA, Kemp BE. Insulin activation of acetyl-CoA carboxylase accompagnied by inhibition of the 5′ AMP-activated protein kinase. J Biol Chem 1992; 267: 2864-2867.
34. Gamble J, Lopaschuck GD. Insulin inhibition of 5′ adenosine monophosphate-activated protein kinase in the heart results in activation of acetyl coenzyme A carboxylase and inhibition of fatty acid oxidation. Metabolism 1997: 46: 1270-1274.
35. Beauloye C, Marsin AS, Bertrand L, Krause U, Hardie DG, Vanoverschelde JL, Hue L. Insulin antagonizes AMP-activated protein kinase activation by ischemia or anoxia in rat hearts, without affecting total adenine nucleotides. FEBS Lett 2001; 505: 348-352.